Roster of the Vaccines and Related Biological Products Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies Including Industry Representative: 4
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

---

Chair

John Modlin, M.D. 
Expertise: Pediatrics
Term: 11/15/2005 – 01/31/2010
Professor of Pediatrics
Dartmouth-Hitchcock Medical Center
Pediatric Administration
One Medical Center Drive
Lebanon, New Hampshire 03756

Designated Federal Officer 
Christine Walsh, R.N.
Center for Biologics Evaluation & Research
Food and Drug Administration
1401 Rockville Pike (HFM-71)
Rockville, Maryland 20852
301-827-0314
fax # 301-827-0294
christine.walsh@fda.hhs.gov

Committee Management Specialist
Denise Royster
Center for Biologics Evaluation & Research
Food and Drug Administration
1401 Rockville Pike (HFM-71)
Rockville, Maryland 20852
301-827-0314
fax # 301-827-0294
denise.royster@fda.hhs.gov

 

Vicky Debold, Ph.D., R.N. *
Expertise: Consumer Representative
Term: 10/31/2007 – 01/31/2010
Director of Patient Safety
National Vaccine Information Center
204 Mill Street, Suite B-1
Vienna, Virginia 22180

 

Frank DeStefano, M.D., M.P.H.
Expertise: Epidemiology
Term: 05/27/2008 – 01/31/2012
Director, Immunization Safety Office
Centers for Disease Control & Prevention
1600 Clifton Road, NE (MS D-26)
Atlanta, Georgia 30333

 

Peter Gilbert, Ph.D.
Expertise: Biostatistics
Term: 05/27/2008 – 01/31/2012
Research Professor
University of Washington
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North, M2-C801
PO Box 19024
Seattle, Washington 98109

 

Lisa Jackson, M.D., M.P.H.
Expertise: Epidemiology & Infec. Dis
Term: 05/25/2006 – 01/31/2010
Senior Scientific Investigator
Group Health Cooperative
1730 Minor Avenue, Suite 1600
Seattle, Washington 98101

 

Margaret Rennels, M.D. **
Expertise: Industry Representative
Term: 03/19/2009 – 01/31/2013
Executive Director
U.S. Scientific Vaccine Policy
GlaxoSmithKline
1050 K Street, NW, Suite 800
Washington, DC 20001

 

Jose Romero, M.D.
Expertise: Pediatric Infectious Diseases
Term: 10/31/2007 – 01/31/2011
Professor of Pediatrics
Chief, Pediatric Infectious Diseases
Arkansas Children’s Hospital
University of Arkansas for Med. Sciences
Director, Clinical Trials Research
Arkansas Children’s Hospital Institute
800 Marshall St. Slot 512-11
Little Rock, Arkansas 72202

 

Pablo Sanchez, M.D.
Expertise: Pediatrics and Perinatal-Neonatal Medicine
Term: 10/31/2007 – 01/31/2011
Professor of Pediatrics
Department of Pediatrics
Division of Neonatal-Perinatal Medicine
University of Texas Southwestern Medical
Center at Dallas
5323 Harry Hines Boulevard
Dallas, Texas 75390

 

Jack Stapleton, M.D.
Expertise: Virology & Infec. Dis.
Term: 05/25/2006 – 01/31/2010
Professor and Director
Division Director of Infectious Diseases
Division of Internal Medicine, SW-54 GH
University of Iowa Hospital Clinic
200 Hawkins Drive
Iowa City, Iowa 52242

 

Consumer Representative *

Non-Voting Industry Representative**